Advertisement

Clinical Rheumatology

, Volume 27, Issue 4, pp 543–545 | Cite as

Infection of total hip prosthesis by Mycobacterium tuberculosis and Mycobacterium chelonae in a patient with rheumatoid arthritis

  • Alex Brown
  • Peter Grubbs
  • Anne-Barbara Mongey
Case Report

Abstract

Atypical mycobacterial infections of the musculoskeletal system are very rare and are generally associated with predisposing factors, such as trauma, use of corticosteroids, or an immunocompromised state. There have only been three reports of Mycobacterium chelonae prosthetic infection of which two cases were associated with total hip arthroplasty and one with total knee arthroplasty and no reports of both Mycobacterium tuberculosis and M. chelonae occurring in the same joint. We report a case of a patient with rheumatoid arthritis treated with low-dose methotrexate (15 mg/week) who developed infection with both M. tuberculosis and M. chelonae after the revision of a prosthetic hip. Joint infections by mycobacteria are clinically indistinguishable from those caused by more common bacterial pathogens and, therefore, diagnosis is often delayed. Recurrent prosthetic hip infections, particularly in immunosuppressive patients, should alert the physician to consider the possibility of both tuberculous and atypical mycobacterial infections. Obtaining appropriate cultures can be critical in making the diagnosis and directing treatment. With the increasing use of immunosuppressive agents, including TNF alpha inhibitors, it is likely that there will be an increase in the number of mycobacterial infections complicating arthroplasties.

Keywords

Immunosuppression Infection Mycobacteria Rheumatoid arthritis 

References

  1. 1.
    Shanbhag V, Kotwal R, Gaitonde A et al (2007) Total hip replacement infected with Mycobacterium tuberculosis. A case report with review of literature. Acta Orthop Belg 73:268–274PubMedGoogle Scholar
  2. 2.
    Vadillo Font C, Hernandez-Garcia C, Pato E et al (2003) Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases. Rev Clin Esp 203:178–182PubMedCrossRefGoogle Scholar
  3. 3.
    Wallace RJ Jr, Brown BA, Onyi GO (1992) Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 166:405–412PubMedGoogle Scholar
  4. 4.
    Wallace RJ Jr, Brown BA (1998) Catheter sepsis due to Mycobacterium chelonae. J Clin Microbiol 36:3444–3445PubMedGoogle Scholar
  5. 5.
    Meyers H, Brown-Elliott BA, Moore D et al (2002) An outbreak of Mycobacterium chelonae infection following liposuction. Clin Infect Dis 34:1500–1507PubMedCrossRefGoogle Scholar
  6. 6.
    Sun YC, Wang IJ, Hu FR (2006) Bilateral Mycobacterium chelonae keratitis after laser in situ keratomileusis. Jpn J Ophthalmol 50:285–287PubMedCrossRefGoogle Scholar
  7. 7.
    Rho M, Bia F, Brewster UC (2007) Nontuberculous mycobacterial peritonitis in peritoneal dialysis patients. Semin Dial 20:271–276PubMedCrossRefGoogle Scholar
  8. 8.
    Mathews PV, Kane TJ 3rd (2005) Total hip arthroplasty infection with Chlamydia pneumoniae and Mycobacterium chelonae. Orthopedics 28:609–610PubMedGoogle Scholar
  9. 9.
    Heathcock R, Dave J, Yates MD (1994) Mycobacterium chelonae hip infection. J Infect 28:104–105PubMedCrossRefGoogle Scholar
  10. 10.
    Pring M, Eckhoff DG (1996) Mycobacterium chelonae infection following a total knee arthroplasty. J Arthroplast 11:115–116CrossRefGoogle Scholar
  11. 11.
    Uslan DZ, Kowalski TJ, Wengenack NL et al (2006) Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol 142:1287–1292PubMedCrossRefGoogle Scholar
  12. 12.
    Brown-Elliott BA, Wallace RJ Jr, Blinkhorn R et al (2001) Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin Infect Dis 33:1433–1434PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2007

Authors and Affiliations

  1. 1.Division of Immunology, Department of Internal MedicineUniversity of Cincinnati College of MedicineCincinnatiUSA
  2. 2.Division of Infectious Diseases, Department of Internal MedicineUniversity of Cincinnati College of MedicineCincinnatiUSA

Personalised recommendations